These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 24498342

  • 1. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
    Maurin H, Chong SA, Kraev I, Davies H, Kremer A, Seymour CM, Lechat B, Jaworski T, Borghgraef P, Devijver H, Callewaert G, Stewart MG, Van Leuven F.
    PLoS One; 2014; 9(2):e87605. PubMed ID: 24498342
    [Abstract] [Full Text] [Related]

  • 2. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
    Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F.
    Am J Pathol; 2008 Mar; 172(3):786-98. PubMed ID: 18258852
    [Abstract] [Full Text] [Related]

  • 3. Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare.
    Maurin H, Seymour CM, Lechat B, Borghgraef P, Devijver H, Jaworski T, Schmidt MV, Kuegler S, Van Leuven F.
    PLoS One; 2013 Mar; 8(5):e63589. PubMed ID: 23704923
    [Abstract] [Full Text] [Related]

  • 4. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    Siman R, Cocca R, Dong Y.
    PLoS One; 2015 Mar; 10(11):e0142340. PubMed ID: 26540269
    [Abstract] [Full Text] [Related]

  • 5. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, Voituron N, Gestreau C, Dutschmann M, Van Leuven F, Hilaire G.
    Respir Physiol Neurobiol; 2011 Sep 15; 178(2):290-303. PubMed ID: 21763469
    [Abstract] [Full Text] [Related]

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.
    Exp Neurol; 2008 Jul 15; 212(1):71-84. PubMed ID: 18490011
    [Abstract] [Full Text] [Related]

  • 7. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
    Maurin H, Lechat B, Borghgraef P, Devijver H, Jaworski T, Van Leuven F.
    Eur J Neurosci; 2014 Jul 15; 40(2):2442-53. PubMed ID: 24754737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.
    Kremer A, Maurin H, Demedts D, Devijver H, Borghgraef P, Van Leuven F.
    J Neurosci; 2011 Dec 07; 31(49):18036-47. PubMed ID: 22159117
    [Abstract] [Full Text] [Related]

  • 10. Trans-synaptic spread of tau pathology in vivo.
    Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K.
    PLoS One; 2012 Dec 07; 7(2):e31302. PubMed ID: 22312444
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
    Crespo-Biel N, Theunis C, Borghgraef P, Lechat B, Devijver H, Maurin H, Van Leuven F.
    Neurobiol Dis; 2014 Jul 07; 67():119-32. PubMed ID: 24704314
    [Abstract] [Full Text] [Related]

  • 12. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.
    Siman R, Lin YG, Malthankar-Phatak G, Dong Y.
    J Neuropathol Exp Neurol; 2013 Nov 07; 72(11):1062-71. PubMed ID: 24128676
    [Abstract] [Full Text] [Related]

  • 13. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA, Barrett GM, Duff KE, Hussaini SA.
    PLoS Biol; 2020 Aug 07; 18(8):e3000851. PubMed ID: 32822389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier.
    Liu Y, Zhang S, Li X, Liu E, Wang X, Zhou Q, Ye J, Wang JZ.
    Biosci Rep; 2020 Feb 28; 40(2):. PubMed ID: 32043530
    [Abstract] [Full Text] [Related]

  • 16. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
    Van der Jeugd A, Hochgräfe K, Ahmed T, Decker JM, Sydow A, Hofmann A, Wu D, Messing L, Balschun D, D'Hooge R, Mandelkow EM.
    Acta Neuropathol; 2012 Jun 28; 123(6):787-805. PubMed ID: 22532069
    [Abstract] [Full Text] [Related]

  • 17. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.
    Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ.
    Glia; 2009 Jan 01; 57(1):54-65. PubMed ID: 18661556
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.